Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 COX-2 and cancer: a new approach to an old problem.

× No keyword cloud information.

155 in total

1. Cyclooxygenase-2 in Barrett's esophagus, Barrett's adenocarcinomas, and esophageal SCC: ready for clinical trials.

Authors: R V Lord; K D Danenberg; P V Danenberg
Journal: Am J Gastroenterol Date: 1999-08 Impact factor: 10.864

Review 2. The PPARs: from orphan receptors to drug discovery.

Authors: T M Willson; P J Brown; D D Sternbach; B R Henke
Journal: J Med Chem Date: 2000-02-24 Impact factor: 7.446

Review 3. Cyclooxygenases: structural, cellular, and molecular biology.

Authors: W L Smith; D L DeWitt; R M Garavito
Journal: Annu Rev Biochem Date: 2000 Impact factor: 23.643

Review 4. Biological activities and mechanisms of action of PGJ2 and related compounds: an update.

Authors: M Fukushima
Journal: Prostaglandins Leukot Essent Fatty Acids Date: 1992-09 Impact factor: 4.006

5. Non-small cell lung cancer cyclooxygenase-2-dependent invasion is mediated by CD44.

Authors: M Dohadwala; J Luo; L Zhu; Y Lin; G J Dougherty; S Sharma; M Huang; M Pold; R K Batra; S M Dubinett
Journal: J Biol Chem Date: 2001-04-24 Impact factor: 5.157

6. Inhibition of COX-2 and induction of apoptosis: two determinants of nonsteroidal anti-inflammatory drugs' chemopreventive efficacies in mouse lung tumorigenesis.

Authors: R Yao; N Rioux; A Castonguay; M You
Journal: Exp Lung Res Date: 2000-12 Impact factor: 2.459

7. Enhanced expression of cyclooxygenase (COX)-2 in human skin epidermal cancer cells: evidence for growth suppression by inhibiting COX-2 expression.

Authors: Y Higashi; T Kanekura; T Kanzaki
Journal: Int J Cancer Date: 2000-06-01 Impact factor: 7.396

8. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue.

Authors: D A Kujubu; B S Fletcher; B C Varnum; R W Lim; H R Herschman
Journal: J Biol Chem Date: 1991-07-15 Impact factor: 5.157

9. Cytoplasmic induction and over-expression of cyclooxygenase-2 in human prostate cancer: implications for prevention and treatment.

Authors: S Madaan; P D Abel; K S Chaudhary; R Hewitt; M A Stott; G W Stamp; E N Lalani
Journal: BJU Int Date: 2000-10 Impact factor: 5.588

10. Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles.

Authors: C C Chan; S Boyce; C Brideau; S Charleson; W Cromlish; D Ethier; J Evans; A W Ford-Hutchinson; M J Forrest; J Y Gauthier; R Gordon; M Gresser; J Guay; S Kargman; B Kennedy; Y Leblanc; S Leger; J Mancini; G P O'Neill; M Ouellet; D Patrick; M D Percival; H Perrier; P Prasit; I Rodger
Journal: J Pharmacol Exp Ther Date: 1999-08 Impact factor: 4.030

32 in total

1. Cyclooxygenase-2 promotes angiogenesis by increasing vascular endothelial growth factor and predicts prognosis in gallbladder carcinoma.

Authors: Ying-Hui Zhi; Ruo-Shan Liu; Mao-Min Song; Yu Tian; Jin Long; Wei Tu; Ren-Xuan Guo
Journal: World J Gastroenterol Date: 2005-06-28 Impact factor: 5.742

2. Expression of p63 and cyclooxygenase-2 and their correlation in skin tumors.

Authors: Yan Wu; Houjun Liu; Jiawen Li
Journal: J Huazhong Univ Sci Technolog Med Sci Date: 2007-04

3. The clinical significance of occult gynecologic primary tumours in metastatic cancer.

Authors: M B Hannouf; E Winquist; S M Mahmud; M Brackstone; S Sarma; G Rodrigues; P K Rogan; J S Hoch; G S Zaric
Journal: Curr Oncol Date: 2017-10-25 Impact factor: 3.677

4. Inhibition of cyclooxygenase-2-dependent survivin mediates decursin-induced apoptosis in human KBM-5 myeloid leukemia cells.

Authors: Quein Ahn; Soo-Jin Jeong; Hyo-Jung Lee; Hee-Young Kwon; Ihn Han; Hyun Seok Kim; Hyo-Jeong Lee; Eun-Ok Lee; Kwang Seok Ahn; Min-Hyung Jung; Shudong Zhu; Chang-Yan Chen; Sung-Hoon Kim
Journal: Cancer Lett Date: 2010-07-31 Impact factor: 8.679

5. The cancer marker neutrophil gelatinase-associated lipocalin is highly expressed in human endometrial hyperplasia.

Authors: Chi-Jr Liao; Yen Hua Huang; Heng-Kien Au; Le-Ming Wang; Sin-Tak Chu
Journal: Mol Biol Rep Date: 2011-05-15 Impact factor: 2.316

Review 6. Pharmacology and potential therapeutic applications of nitric oxide-releasing non-steroidal anti-inflammatory and related nitric oxide-donating drugs.

Authors: J E Keeble; P K Moore
Journal: Br J Pharmacol Date: 2002-10 Impact factor: 8.739

Review 7. Prospective of colon cancer treatments and scope for combinatorial approach to enhanced cancer cell apoptosis.

Authors: Jayshree Mishra; Joseph Drummond; Sohel H Quazi; Satya Sridhar Karanki; J J Shaw; Ben Chen; Narendra Kumar
Journal: Crit Rev Oncol Hematol Date: 2012-10-23 Impact factor: 6.312

Review 8. Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms.

Authors: Mohammad Athar; Jung Ho Back; Levy Kopelovich; David R Bickers; Arianna L Kim
Journal: Arch Biochem Biophys Date: 2009-06-15 Impact factor: 4.013

9. Concurrent targeting of eicosanoid receptor 1/eicosanoid receptor 4 receptors and COX-2 induces synergistic apoptosis in Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus associated non-Hodgkin lymphoma cell lines.

Authors: Arun George Paul; Bala Chandran; Neelam Sharma-Walia
Journal: Transl Res Date: 2013-03-20 Impact factor: 7.012

Review 10. Molecular targets of nutraceuticals derived from dietary spices: potential role in suppression of inflammation and tumorigenesis.

Authors: Bharat B Aggarwal; Michelle E Van Kuiken; Laxmi H Iyer; Kuzhuvelil B Harikumar; Bokyung Sung
Journal: Exp Biol Med (Maywood) Date: 2009-06-02